Pharmaceutical Technology
MAY 25, 2023
The biobank will work in parallel with the MHRA’s Yellow Card website, which is used for reporting adverse events and side effects caused by medicines and medical devices, per the 25 May announcement. Side effects due to drugs are responsible for one in every 16 hospital admissions in the UK, based on the announcement.
pharmaphorum
JANUARY 3, 2023
” Rawlins was knighted in the 1999 Queen’s New Year Honours for services to the improvement of patient protection from the side effects of medicines, and in 2017 was appointed Knight Grand Cross of the Order of the British Empire (GBE) for services to the safety of medicines, healthcare, and innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 27, 2023
As for Briumvi’s side effects, around 45% of patients experienced infections of the upper respiratory tract, which was 4% higher in comparison to Aubagio. As for Briumvi’s side effects, around 45% of patients experienced infections of the upper respiratory tract, which was 4% higher in comparison to Aubagio.
European Pharmaceutical Review
JULY 20, 2022
Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. This is usually on a much larger scale than is possible in clinical trials and can uncover less common side effects. Supporting regulators. Study focus. almitrine – a respiratory stimulant.
European Pharmaceutical Review
DECEMBER 14, 2023
Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 Lane S, Lynn E, Shakir S.
PM360
OCTOBER 24, 2022
received FDA approval for once-daily GEMTESA—the first new oral OAB medication approved by the FDA since 2012. With all of this, GEMTESA was shown to be safe and tolerable—with only 2% of study participants discontinuing GEMTESA due to side effects. In December 2020, a startup out of southern California, Urovant Sciences, Inc.,
Pharmaceutical Technology
APRIL 24, 2023
While 80% of the world’s population practices some form of traditional medicine, according to the World Health Organization (WHO), the practice is regularly discredited due to a lack of scientific support and regulation as well as evidence of negative side effects with certain medicines.
Expert insights. Personalized for you.
52 
Let's personalize your content